180 related articles for article (PubMed ID: 16178559)
1. Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.
Lee M; Bernardo MM; Meroueh SO; Brown S; Fridman R; Mobashery S
Org Lett; 2005 Sep; 7(20):4463-5. PubMed ID: 16178559
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
Lee M; Villegas-Estrada A; Celenza G; Boggess B; Toth M; Kreitinger G; Forbes C; Fridman R; Mobashery S; Chang M
Chem Biol Drug Des; 2007 Nov; 70(5):371-82. PubMed ID: 17927722
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.
Moroy G; Denhez C; El Mourabit H; Toribio A; Dassonville A; Decarme M; Renault JH; Mirand C; Bellon G; Sapi J; Alix AJ; Hornebeck W; Bourguet E
Bioorg Med Chem; 2007 Jul; 15(14):4753-66. PubMed ID: 17512742
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
7. 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
Zhang YM; Fan X; Chakaravarty D; Xiang B; Scannevin RH; Huang Z; Ma J; Burke SL; Karnachi P; Rhodes KJ; Jackson PF
Bioorg Med Chem Lett; 2008 Jan; 18(1):409-13. PubMed ID: 17981034
[TBL] [Abstract][Full Text] [Related]
8. A combined molecular modeling study on gelatinases and their potent inhibitors.
Xi L; Du J; Li S; Li J; Liu H; Yao X
J Comput Chem; 2010 Jan; 31(1):24-42. PubMed ID: 19412908
[TBL] [Abstract][Full Text] [Related]
9. Purification and structure determination of gelatinase and collagenase inhibitors from Viola patrinii fermentation extracts.
Kim KS; Kwak YJ; Kim KM; Yu HY; Kang BW; Chung E; Lee YC; Kim JI; Lee JH
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):614-6. PubMed ID: 20196628
[TBL] [Abstract][Full Text] [Related]
10. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.
Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A
Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).
Zhang YM; Fan X; Yang SM; Scannevin RH; Burke SL; Rhodes KJ; Jackson PF
Bioorg Med Chem Lett; 2008 Jan; 18(1):405-8. PubMed ID: 17980583
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M; Campestre C; Preziuso S; Consalvi V; Crucianelli M; Mazza F; Politi V; Ragno R; Tortorella P; Gallina C
Eur J Med Chem; 2005 Mar; 40(3):271-9. PubMed ID: 15725496
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
Krüger A; Arlt MJ; Gerg M; Kopitz C; Bernardo MM; Chang M; Mobashery S; Fridman R
Cancer Res; 2005 May; 65(9):3523-6. PubMed ID: 15867341
[TBL] [Abstract][Full Text] [Related]
14. Assessing the bioisosterism of the trifluoromethyl group with a protease probe.
Jagodzinska M; Huguenot F; Candiani G; Zanda M
ChemMedChem; 2009 Jan; 4(1):49-51. PubMed ID: 19065645
[No Abstract] [Full Text] [Related]
15. Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.
Ledour G; Moroy G; Rouffet M; Bourguet E; Guillaume D; Decarme M; Elmourabit H; Augé F; Alix AJ; Laronze JY; Bellon G; Hornebeck W; Sapi J
Bioorg Med Chem; 2008 Sep; 16(18):8745-59. PubMed ID: 18782669
[TBL] [Abstract][Full Text] [Related]
16. A convenient synthesis of a selective gelatinase inhibitor as an antimetastatic agent.
Lim IT; Brown S; Mobashery S
J Org Chem; 2004 May; 69(10):3572-3. PubMed ID: 15132575
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.
Yan Y; Chen X; Yang X; Zhang J; Xu W; Zhang Y
Bioorg Med Chem; 2015 Oct; 23(20):6632-40. PubMed ID: 26386821
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of myxochelin analogues as antimetastatic agents.
Miyanaga S; Sakurai H; Saiki I; Onaka H; Igarashi Y
Bioorg Med Chem; 2009 Apr; 17(7):2724-32. PubMed ID: 19282185
[TBL] [Abstract][Full Text] [Related]
19. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
Shang L; Wang Q; Fang H; Mu J; Wang X; Yuan Y; Wang B; Xu W
Bioorg Med Chem; 2008 Dec; 16(23):9984-90. PubMed ID: 18996018
[TBL] [Abstract][Full Text] [Related]
20. Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells.
Mendis E; Kim MM; Rajapakse N; Kim SK
Bioorg Med Chem Lett; 2006 Jun; 16(12):3105-10. PubMed ID: 16616490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
